CPIX
CPIX clinical trials: CUMBERLAND PHARMACEUTICALS INC
Every trial on ClinicalTrials.gov where CUMBERLAND PHARMACEUTICALS INC is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 65
- Trials linked
- 49
- As lead sponsor
- 16
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
CPIX on the catalyst calendar · CPIX registry changes
- Primary completion Jan 2028Sponsor estimatePhase 2NCT05571059Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)Cumberland Pharmaceuticals · Idiopathic Pulmonary FibrosisRecruitingCPIXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2026ActualPhase 2NCT02682511Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial HypertensionCumberland Pharmaceuticals · Scleroderma, DiffuseActive, not recruitingCPIXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 6, 2024ActualPhase 2NCT03340675Oral Ifetroban in Subjects With Duchenne Muscular DystrophyCumberland Pharmaceuticals · Duchenne Muscular Dystrophy CardiomyopathyCompletedCPIXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 25, 2023ActualPhase 2NCT03028350Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD)Cumberland Pharmaceuticals · Asthma, Aspirin-InducedCompletedCPIXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2012ActualPhase 4NCT01334957Surgical Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous IbuprofenCumberland Pharmaceuticals · PainCompletedCPIXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2021ActualPhase 1NCT02013141Telavancin Pediatric PK Study (Ages >12 Months to 17 Years)Cumberland Pharmaceuticals · Gram-Positive Bacterial InfectionsTerminatedCPIXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 2012ActualPhase 4NCT01334944Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous IbuprofenCumberland Pharmaceuticals · PainCompletedCPIXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 17, 2020ActualPhase 2NCT03611010Dose-ranging Efficacy and Pharmacokinetics Study of Intravenous Atorvastatin in Hypercholesterolemic PatientsCumberland Pharmaceuticals · HypercholesterolemiaCompletedCPIXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 17, 2018ActualPhase 2NCT02802228Study to Assess Safety and Efficacy of Ifetroban for Treatment of Portal Hypertension in Cirrhotic PatientsCumberland Pharmaceuticals · Portal HypertensionCompletedCPIXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 2, 2019ActualPhase 4NCT02583399Safety and Pharmacokinetic Study of Intravenous Ibuprofen in Pediatric PatientsCumberland Pharmaceuticals · PainCompletedCPIXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 2020ActualNo phase registeredNCT01130324VIBATIV Pregnancy RegistryCumberland Pharmaceuticals · PregnancyWithdrawnCPIXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 12, 2018ActualPhase 3NCT02208063A Phase 3 Telavancin Staphylococcus Aureus (S. Aureus) Bacteremia TrialCumberland Pharmaceuticals · BacteremiaTerminatedCPIXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2017ActualNo phase registeredNCT02288234Telavancin Observational Use Registry (TOUR)Cumberland Pharmaceuticals · Hospital Acquired Bacterial PneumoniaCompletedCPIXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 2011ActualPhase 1NCT01238796A Study to Evaluate the Effect of Renal Function on the Biological Activity of TelavancinCumberland Pharmaceuticals · Kidney DiseasesCompletedCPIXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 2007ActualPhase 3NCT00124020Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus AureusCumberland Pharmaceuticals · Bacterial PneumoniaCompletedCPIXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 2006ActualPhase 3NCT00107978Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant...Cumberland Pharmaceuticals · Staphylococcal Skin InfectionCompletedCPIXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 2007ActualPhase 3NCT00107952Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus AureusCumberland Pharmaceuticals · Bacterial PneumoniaCompletedCPIXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2006ActualPhase 3NCT00091819Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant...Cumberland Pharmaceuticals · Staphylococcal Skin InfectionCompletedCPIXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 2004ActualPhase 2NCT00077675Phase 2 Trial of TD-6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram...Cumberland Pharmaceuticals · Infections, Gram-positive BacterialCompletedCPIXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 2006ActualPhase 2NCT00062647Telavancin for Treatment of Uncomplicated Staphylococcus Aureus BacteremiaCumberland Pharmaceuticals · Gram-Positive Bacterial InfectionsCompletedCPIXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 2004ActualPhase 2NCT00061633Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram...Cumberland Pharmaceuticals · Infections, Gram-Positive BacterialCompletedCPIXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 2016ActualPhase 2NCT02216357Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory DiseaseCumberland Pharmaceuticals · Aspirin Exacerbated Respiratory Disease (AERD)CompletedCPIXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2015ActualPhase 2NCT01436500Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome PatientsCumberland Pharmaceuticals · Hepatorenal SyndromeCompletedCPIXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2013ActualPhase 3NCT01002573Safety, Efficacy, and Pharmacokinetic Study of Intravenous Ibuprofen in Pediatric PatientsCumberland Pharmaceuticals · FeverCompletedCPIXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 2012ActualPhase 3NCT01332253Safety and Efficacy of Intravenous Ibuprofen for Treatment of Pain in Pediatric Patients Undergoing TonsillectomyCumberland Pharmaceuticals · TonsillectomyCompletedCPIXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 25 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScannerShowing the first 25 trials. There are 40 more in this window; the full list is part of TrialScanner.
Unlock with TrialScanner